AnaptysBio
Utility Patents
Last updated:
List of all AnaptysBio patents 7 in total
| Status | Patent |
|---|---|
Grant | Utility: Antibodies directed against programmed death-1 (PD-1) Filling date: 7 Sep 2025 Issue date: 26 Oct 2021 |
Grant | Utility: Method of treating pustular psoriasis with antibodies directed against interleukin 36 receptor (IL-36R) Filling date: 7 Sep 2025 Issue date: 28 Sep 2021 |
Grant | Utility: Method of treating inflammatory disorder with antibodies directed against interleukin-33 (IL-33) Filling date: 7 Sep 2025 Issue date: 17 Nov 2020 |
Grant | Utility: Antibodies directed against lymphocyte activation gene 3 (LAG-3) Filling date: 7 Sep 2025 Issue date: 17 Nov 2020 |
Grant | Utility: Antibodies directed against programmed death-1 (PD-1) Filling date: 7 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Antibodies directed against interleukin 36 receptor (IL-36R) Filling date: 7 Sep 2025 Issue date: 7 Jan 2020 |
Grant | Utility: Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3) Filling date: 7 Sep 2025 Issue date: 17 Dec 2019 |
Showing 1 to 7 of 7 patents.